DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,731 Cr |
| Mar2024 | ₹2,156 Cr |
| Mar2023 | ₹1,793 Cr |
| Mar2022 | ₹2,424 Cr |
| Mar2021 | ₹1,677 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,731 Cr | 26.67 | |
| Mar2024 | ₹2,156 Cr | 20.25 | |
| Mar2023 | ₹1,793 Cr | -26.03 | |
| Mar2022 | ₹2,424 Cr | 44.58 | |
| Mar2021 | ₹1,677 Cr | - | |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹181,888.7 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,911.0 Cr | -0.3% | 7.9% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 4.2% |
3.9% |
1.5% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses